Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 21 | 3 | 2 | 0 | 1 |
Analyst Firms Making Recommendations1
- JP Morgan
- Stephens & Co.
- Goldman Sachs
- Wells Fargo
- Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for HCA Healthcare
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/17/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 6.39% | JP Morgan | Samik Chatterjee | $313 → $265 | Maintains | Neutral | Get Alert |
| 11/10/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 12.41% | Stephens & Co. | Scott Fidel | → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 12.82% | Goldman Sachs | Jamie Perse | $329 → $281 | Maintains | Buy | Get Alert |
| 10/26/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 1.98% | Wells Fargo | Stephen Baxter | $267 → $254 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 20.44% | Truist Securities | David Macdonald | $340 → $300 | Maintains | Buy | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 10.41% | Mizuho | Ann Hynes | $325 → $275 | Maintains | Buy | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 14.02% | RBC Capital | Ben Hendrix | $315 → $284 | Maintains | Outperform | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 12.41% | Stephens & Co. | Scott Fidel | $300 → $280 | Maintains | Overweight | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 12.01% | Citigroup | Jason Cassorla | $324 → $279 | Maintains | Buy | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 12.41% | Raymond James | John Ransom | $320 → $280 | Maintains | Outperform | Get Alert |
| 10/20/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 7.19% | Wells Fargo | Stephen Baxter | $275 → $267 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 26.47% | Cantor Fitzgerald | Sarah James | → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 26.47% | RBC Capital | Ben Hendrix | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 26.87% | Credit Suisse | A.J. Rice | $311 → $316 | Maintains | Outperform | Get Alert |
| 07/28/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 26.47% | Oppenheimer | Michael Wiederhorn | $310 → $315 | Maintains | Outperform | Get Alert |
| 07/11/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 30.48% | Mizuho | Ann Hynes | $305 → $325 | Maintains | Buy | Get Alert |
| 06/28/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 20.44% | Barclays | Steve Valiquette | $275 → $300 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 36.5% | Truist Securities | David Macdonald | $325 → $340 | Maintains | Buy | Get Alert |
| 05/16/2023 | HCA | Buy Now | HCA Healthcare | $249.08 | 22.45% | Mizuho | Ann Hynes | $298 → $305 | Maintains | Buy | Get Alert |
What is the target price for HCA Healthcare (HCA)?
The latest price target for HCA Healthcare (NYSE: HCA) was reported by JP Morgan on November 17, 2023. The analyst firm set a price target for $265.00 expecting HCA to rise to within 12 months (a possible 6.39% upside). 56 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCA Healthcare (HCA)?
The latest analyst rating for HCA Healthcare (NYSE: HCA) was provided by JP Morgan, and HCA Healthcare maintained their neutral rating.
When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating HCA Healthcare (HCA) correct?
While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a maintained with a price target of $313.00 to $265.00. The current price HCA Healthcare (HCA) is trading at is $249.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.